XOMA Royalty Corp. (XOMA)
28.81
-0.55
(-1.87%)
USD |
NASDAQ |
Jan 15, 13:15
XOMA Royalty SG&A Expense (TTM): 32.68M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Mirum Pharmaceuticals, Inc. | 239.73M |
| Recursion Pharmaceuticals, Inc. | 220.12M |
| Rezolute, Inc. | 20.85M |
| Vistagen Therapeutics, Inc. | 17.01M |
| Zevra Therapeutics, Inc. | 73.39M |